[维拉帕米对多发性骨髓瘤患者血小板功能的影响]
[The influence of verapamil on platelet function in patients with multiple myeloma].
作者信息
Sokołowska B, Dmoszyńska A, Walter-Croneck A, Wojtaszko M
机构信息
Kliniki Hematologii Akademii Medycznej w Lublinie.
出版信息
Pol Merkur Lekarski. 1997 Feb;2(8):109-10.
PMID:9538652
Abstract
Influence of verapamil on platelet function was evaluated in 7 female and 8 male patients with myeloma. The inhibitory effect on platelet aggregation and other parameters was documented in clinical observation.
摘要
在7名女性和8名男性骨髓瘤患者中评估了维拉帕米对血小板功能的影响。临床观察记录了其对血小板聚集及其他参数的抑制作用。
相似文献
1
[The influence of verapamil on platelet function in patients with multiple myeloma].[维拉帕米对多发性骨髓瘤患者血小板功能的影响]
Pol Merkur Lekarski. 1997 Feb;2(8):109-10.
2
[Chemotherapy of multiple myeloma].[多发性骨髓瘤的化疗]
Sov Med. 1991(3):43-6.
3
[Pneumonia caused by Salmonella in a patient with myeloma].[一名骨髓瘤患者的沙门氏菌肺炎]
Sangre (Barc). 1995 Jun;40(3):234-5.
4
5
6
Refractory multiple myeloma treated with homoharringtonine: report of two cases.高三尖杉酯碱治疗难治性多发性骨髓瘤：两例报告
Ann Hematol. 2007 Dec;86(12):919-21. doi: 10.1007/s00277-007-0331-5. Epub 2007 Jul 20.
7
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.
Cancer Treat Rep. 1984 Dec;68(12):1439-46.
8
Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.多发性骨髓瘤的细胞动力学与治疗：M83方案的更新
Bone Marrow Transplant. 1989 Jan;4 Suppl 1:168-9.
9
Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
Arch Immunol Ther Exp (Warsz). 1981;29(2):145-53.
10
[Preleukemia myelodysplastic syndrome after chemotherapy for multiple myeloma: "a new case"].多发性骨髓瘤化疗后白血病前期骨髓增生异常综合征：“1例新病例”
Sangre (Barc). 1991 Oct;36(5):434-5.
Zotero 插件